Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Zoom Video Communications, Inc. — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Zoom Video Communications, Inc. trades at $93.24 (market cap $28.64B). The key difference: Zoom Video Communications, Inc. is far larger — about 29.4× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Maravai LifeSciences Holdings Inc. Class A Common Stock is more actively traded (4,325,710 versus 2,595,677). Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Zoom Video Communications, Inc. for 92 Days on average.
| MRVI | ZM | |
|---|---|---|
Market Cap | $972.90M | $28.64B |
Volume | 4,325,710 | 2,595,677 |
Sector | Health | Technology |
52-Week High | $9.00 | $111.88 |
52-Week Low | $2.83 | $72.72 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $1.08B | $21.45B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Zoom Communications (ZM) trades at $94.47, down 3.54% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $118.08. The company reported strong profitability with a net income margin of 65.19% in 2026 and is advancing its AI-powered revenue OS, positioning for growth amid recent earnings beats.
The stock presents a compelling opportunity given its attractive valuation (P/E of 9.11) and robust fundamentals, though risks include reliance on international sales and competitive pressures in the communication software sector. Upside potential exists if the company executes on its AI initiatives and maintains earnings momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
